ArticleBMC pulmonary medicine2024

Optimized anti-tuberculosis duration for drug-susceptible pulmonary tuberculosis-diabetes mellitus comorbidities: study protocol for a multicenter randomized controlled trial.

Peize Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.